Lianlian Liu

P.R. China
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

METTL5-mediated m6A modification of 18S rRNA drives oral squamous cell carcinoma progression by enhancing CCND3 translation.

METTL5-mediated m6A modification of 18S rRNA drives oral squamous cell carcinoma progression by enhancing CCND3 translation.

Journal: Oncology letters
Published: June 15, 2025

NSUN2 Promotes Head and Neck Squamous Cell Carcinoma Progression by Targeting EMT-Related Gene LAMC2 in an m5C-YBX1-Dependent Manner.

NSUN2 Promotes Head and Neck Squamous Cell Carcinoma Progression by Targeting EMT-Related Gene LAMC2 in an m5C-YBX1-Dependent Manner.

Journal: Biomedicines
Published: August 29, 2024

Squamous papilloma involving the mandible: A case report and descriptive literature review.

Squamous papilloma involving the mandible: A case report and descriptive literature review.

Journal: Experimental and therapeutic medicine
Published: October 27, 2023

RNA modification-related genes illuminate prognostic signature and mechanism in esophageal squamous cell carcinoma.

RNA modification-related genes illuminate prognostic signature and mechanism in esophageal squamous cell carcinoma.

Journal: iScience
Published: October 02, 2023

METTL3 inhibitor STM2457 impairs tumor progression and enhances sensitivity to anlotinib in OSCC.

METTL3 inhibitor STM2457 impairs tumor progression and enhances sensitivity to anlotinib in OSCC.

Journal: Oral diseases
Published: August 21, 2023

NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer.

NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer.

Journal: Cell reports
Published: March 18, 2023

METTL1/WDR4-mediated tRNA m7G modification and mRNA translation control promote oncogenesis and doxorubicin resistance.

METTL1/WDR4-mediated tRNA m7G modification and mRNA translation control promote oncogenesis and doxorubicin resistance.

Journal: Oncogene
Published: December 10, 2022

METTL3-mediated ALDH m6A methylation regulates the malignant behavior of BMI1+ HNSCC stem cells.

METTL3-mediated ALDH m6A methylation regulates the malignant behavior of BMI1+ HNSCC stem cells.

Journal: Oral diseases
Published: September 22, 2022
Showing 1-8 of 8

Last Updated: 09/26/2026